This article first appeared on GuruFocus .
-
Revenue:Just under EUR4.9 billion, up 8% year-over-year.
-
EBITDA:EUR626 million, up 9%.
-
Trading Profit:EUR487 million, up 10% (net of EUR4.5 million Advances IPO exploration costs; underlying growth of 13% on a currency-adjusted basis).
-
Earnings Per Share:Up 5%.
-
Interim Dividend:EUR0.271 per share, up 3%.
-
Free Cash Flow:EUR144 million.
-
Trading Margin:10%, up 20 basis points.
-
Net Debt-to-EBITDA:1.56x.
-
Revenue by Segment (pre-currency):Building Envelope up 4%; Advances (data-focused) up 36%.
-
Revenue by Geography:Americas up 21% constant currency; Rest of World up over 25%.
-
Working Capital to Sales Ratio:Improved to 12.3% in June 2026 from 13.1% in June 2025.
-
Capital Expenditure:A little under EUR156 million in H1; full-year guidance of EUR360 million.
-
Full-Year Guidance:Trading profit of EUR1.125 billion (implying ~25% H2 growth); revenue expected to break EUR10 billion.
Release Date: August 07, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Strong first-half performance with revenue up 8% to EUR4.9 billion and trading profit up 10% to EUR487 million, despite a difficult Q1.
-
Advances business (data center solutions) revenue surged 36% pre-currency, with order book visibility of around one year and expectations to exceed the EUR600 million EBITDA target well before 2030.
-
Upgraded full-year trading profit guidance to EUR1.125 billion, implying 25% growth in H2, with momentum expected to continue into 2027 (EUR1.3 billion organic target).
-
Margin expansion is on track, with group trading margin expected to reach ~11% for the full year and ~12% in H2, driven by innovation and product mix rather than just pricing.
-
Strong balance sheet with net debt-to-EBITDA at 1.56x, EUR1.3 billion liquidity, and ~EUR1 billion M&A headroom while maintaining investment-grade rating.
-
US commercial roofing rollout is on plan, with revenue expected to approach $200 million next year and positive contribution, supported by new plants in Oklahoma, Maryland, and Utah.
-
Order intake for insulated panels grew 13% by volume globally, with strong performance in Iberia, France, Germany, North America, and Latin America, indicating robust demand.
Negative Points
-
Currency headwinds negatively impacted revenue by EUR61 million (1.5%) and trading profit by EUR8.4 million (2%) in H1.
-
First quarter was difficult worldwide, with Building Envelope sales down 2% pre-currency in Q1, though recovering in Q2.
-
The company paused its share buyback program to preserve dry powder for M&A, which may disappoint some investors expecting capital returns.
-
Input cost inflation (chemicals and steel) remains a moving piece, with potential for steel prices to push higher in H2, though management expects to recover costs.
-
The UK market remains subdued, particularly in the residential sector, with no standout recovery expected until H2.
-
Advances IPO exploration costs of EUR4.5 million were incurred in H1, and the IPO is now off the table, which may limit strategic flexibility for that business.
-
CapEx is elevated at EUR360 million for 2026 and similar for 2027, which could pressure free cash flow if not matched by returns.
Q & A Highlights
Q: Can you elaborate on the exceptional 13% panel order intake growth and the medium-term targets for the Advances business, which appears to be running significantly ahead of the initial EUR300 million EBITDA guidance for 2026? A: Gene Murtagh (CEO): The 13% volume growth in insulated panel orders is a global trend, with strong performances in Iberia, France, Germany, North America, and Latin America, driven by penetration growth and new product introductions. For Advances, we now expect 2026 EBITDA to be around EUR400 million, and we are highly confident of breaking through the EUR600 million target for 2030 well ahead of schedule on an organic basis, excluding any acquisitions.
Q: Regarding the "dry powder" comment, what is the balance sheet capacity for M&A, and is the 2x leverage a hard cap? Would you consider using equity for a deal? A: Gene Murtagh (CEO) & Geoff Doherty (CFO): We have no intention of issuing equity anytime soon. Maintaining our investment-grade rating is paramount, so we will not stretch leverage beyond 2x. This gives us approximately EUR1 billion of headroom for acquisitions, and we have a robust pipeline of opportunities to fill that scope.
Q: With the margin guidance rising to 11% for 2026, are we in a new dynamic of margin progression, and should we expect further expansion from here? A: Geoff Doherty (CFO): We expect the second-half trading margin to be close to 12%, bringing the full-year to around 11%. This is a developmental trend, not a one-off. We expect to incrementally add to margins each year through innovation, new products, and developing our end markets, rather than relying on price recovery alone.
Q: Can you provide a sense of the organic growth expected in the second half for the Envelope business, and how it breaks down between price and volume given input cost inflation? A: Geoff Doherty (CFO) & Gene Murtagh (CEO): We expect top-line growth in Envelopes to be better than the 4% seen in the first half. We won't break down price versus volume, but we have largely recovered cost inflation through pricing. We expect margins in Envelopes to be north of 11% in the second half, driven by a combination of volume and pricing across different markets.
Q: Is the potential IPO of the Advances business now completely behind us, and what is the outlook for input cost inflation in the second half? A: Gene Murtagh (CEO): The IPO discussion is over; Advances is a central part of Kingspan. On inflation, we have largely absorbed the expected cost increases in the second quarter. Steel may push up slightly, while chemical costs should remain broadly stable. We have done a good job on cost recovery, and we expect selling prices to be broadly stable in the second half.
Q: Which segments give you the most confidence in achieving the EUR1.3 billion trading profit target for 2027, and can you break down the Advances performance between new and existing facilities? A: Gene Murtagh (CEO): Confidence for 2027 is broad-based. We see recovery in the EU, strong forward project engagement in North America (particularly tech-oriented), and excellent volume growth in Latin America. New products like OneDek are gaining traction. For Advances, we have an order bank of around one year, providing strong visibility, though we didn't break down the contribution between new and existing facilities.
Q: When will the EUR600 million EBITDA target for Advances be achieved, and does the Utah plant fall under the previously announced $1 billion investment? A: Gene Murtagh (CEO) & Geoff Doherty (CFO): The EUR600 million target will be achieved long before 2030. The Utah facility is absolutely part of the $1 billion organic and acquisition investment, which is well underway. Full-year CapEx guidance remains at approximately EUR360 million for 2026, with a similar level expected for 2027.
Q: What are the key areas of interest for M&A, and what is your decision framework regarding valuation limits and potential temporary dilution of returns? A: Gene Murtagh (CEO) & Geoff Doherty (CFO): The focus is broad, but fleshing out the Advances portfolio to increase share of wallet with hyperscalers is critical. Residential roofing is not a high priority. We are focused on returns on capital and would only consider deals that we aspire to incrementally add to returns over time, without materially altering the group's returns profile.
Q: What are the key levers driving the expected margin expansion to 12% in the second half, and how sustainable are these margins in the medium term? A: Geoff Doherty (CFO): The 12% is a trading margin, which is typically higher in the second half due to the trading cycle. The expansion is driven by a combination of levers, including new products, segment growth, and innovation. We expect to incrementally add to margins each year in a developmental way, rather than relying on price recovery, which rarely makes the difference between a good or bad year.
Q: Can you provide the split between data and non-data sales in Advances, and is the 50% data target now conservative? Also, can you update on the board capacity repurposing strategy in Europe? A: Gene Murtagh (CEO): We haven't provided the exact split, but the shift towards data is increasing rapidly, and we are confident it will exceed 50% in the not-too-distant future. On repurposing, we are moving one European plant to the US for polyiso roofing and another to Brazil to break into that market, both projects are underway.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
